Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2007 Filed Feb 2, 2007 23:38 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 31,920 | $42.50 | $1,356,529.78 |
DisclosureSEC source: 0001104659-07-006964 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,879 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 23 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Underlying: common shares · 1,879 shares Expires 2008-02-12 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 13,270 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 22 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,270 Underlying: common shares · 13,270 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 17,920 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 21 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,920 Underlying: common shares · 17,920 shares Expires 2014-02-19 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 13,588 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 20 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,588 Underlying: common shares · 13,588 shares Expires 2014-08-02 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,033 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 19 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 7,033 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 18 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,941 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 17 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,941 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 15,481 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 16 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,621 Underlying: common shares · 15,481 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,281 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 15 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,639 Underlying: common shares · 21,281 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 16,667 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · derivative · entry 14 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: common shares · 16,667 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 48,689 | $53.19 | $2,589,767.91 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,941 Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 7,033 | $53.04 | $373,030.32 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,630 Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 7,033 | $45.47 | $319,806.69 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,941 | $27.43 | $108,112.66 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 15,481 | $42.42 | $656,704.02 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 21,281 | $41.03 | $873,195.61 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 16,667 | $39.26 | $654,346.42 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GiftCommon shares without par value | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self for son Disclosed balance after: 845 F4 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons. Read SEC document |
| January 31, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GiftCommon shares without par value | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self for son Disclosed balance after: 845 F4 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons. Read SEC document |
| January 31, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GiftCommon shares without par value | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 9 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 845 F4 · ownership.nature: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons. Read SEC document |
| January 31, 2007 Filed Feb 20, 2007 21:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GiftCommon shares without par value | 1,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-012305 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,829 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 1,144 | $0.00 Strike: $51.06 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,144 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,142 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 20,702 | $0.00 Strike: $45.80 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 20,702 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 23,988 | $53.03 | $1,271,978.09 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,359 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 1,144 | $51.06 | $58,411.95 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 2,142 | $46.65 | $99,924.30 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 20,702 | $45.80 | $948,079.14 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 2,881 | $0.00 Strike: $30.20 | $0.00 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · derivative · entry 12 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,881 shares Expires 2007-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,436 | $0.00 Strike: $30.24 | $0.00 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · derivative · entry 11 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,436 shares Expires 2007-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,383 | $0.00 Strike: $31.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · derivative · entry 10 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,383 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,393 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · derivative · entry 9 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,393 shares Expires 2007-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
SaleCommon shares without par value | 2,881 | $53.08 | $152,926.36 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 8 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,650 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionCommon shares without par value | 2,881 | $30.20 | $86,994.10 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 7 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
SaleCommon shares without par value | 1,436 | $53.08 | $76,224.32 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 6 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,650 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionCommon shares without par value | 1,436 | $30.24 | $43,428.66 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 5 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
SaleCommon shares without par value | 1,383 | $53.08 | $73,411.02 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 4 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,650 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionCommon shares without par value | 1,383 | $31.43 | $43,463.54 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 3 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
SaleCommon shares without par value | 1,393 | $53.08 | $73,941.83 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 2 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,650 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:35 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionCommon shares without par value | 1,393 | $26.88 | $37,441.47 |
DisclosureSEC source: 0001104659-07-006560 · a4.xml · nonDerivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,217 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 18 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217 Underlying: Common shares · 1,217 shares Expires 2008-06-29 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 4,842 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 17 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,842 Underlying: Common shares · 4,842 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,488 | $0.00 Strike: $39.04 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 16 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common shares · 1,488 shares Expires 2008-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,275 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · derivative · entry 15 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,275 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 6,059 | $52.66 | $319,066.94 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,885 Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,488 | $39.04 | $58,090.48 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 6,275 | $34.77 | $218,198.69 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC |
Fiorentino Edward JSenior Vice President
|
GrantOption (right to buy) · Derivative | 14,107 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · derivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107 Underlying: Common shares · 14,107 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.